Molecular mechanisms involved in the beneficial effect of BET inhibition in experimental renal disease

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
- Luis M Ruilope, MD
BET inhibition in renal and cardiovascular disease: What is the clinical roadmap?
BET inhibition in renal and cardiovascular disease: What is the clinical roadmap?
Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
BET inhibition in renal and cardiovascular disease: What is the clinical roadmap?
- Kamyar Kalantar-Zade, MD